Literature DB >> 2889667

Enhancement of the interleukin 2 receptor expression on T cells by multiple B-lymphotropic lymphokines.

T Noma1, T Mizuta, A Rosén, T Hirano, T Kishimoto, T Honjo.   

Abstract

Three new human lymphokines, interleukin-5, BSF-2 and BSF-MP6, were shown to be active in the enhancement of the IL-2 receptor expression on T cells, although they do not stimulate growth of the T cells.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2889667     DOI： 10.1016/0165-2478(87)90032-0

Source DB:  PubMed          Journal:  Immunol Lett        ISSN： 0165-2478            Impact factor:   3.685


  25 in total

Review 1.  Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody.

Authors:  K Yoshizaki; N Nishimoto; M Mihara; T Kishimoto
Journal:  Springer Semin Immunopathol       Date:  1998

2.  Partial correction of defective generation of lymphokine-activated killer cells in patients with chronic myelogenous leukaemia after in vivo treatment with interferon-alpha (Wellferon).

Authors:  G Pawelec; E Schneider; G Ehninger; A Rehbein; H Schmidt
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Characterization of high-affinity receptors for interleukin 5 on interleukin 5-dependent cell lines.

Authors:  S Mita; A Tominaga; Y Hitoshi; K Sakamoto; T Honjo; M Akagi; Y Kikuchi; N Yamaguchi; K Takatsu
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

4.  Interleukin 2-dependent and interleukin 2-independent pathways of regulation of thymocyte function by interleukin 6.

Authors:  J M Le; G Fredrickson; L F Reis; T Diamantstein; T Hirano; T Kishimoto; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

5.  Activation and proliferation of normal resting human T lymphocytes in serum-free culture: role of IL-4 and IL-6.

Authors:  D Habetswallner; E Pelosi; D Bulgarini; A Camagna; P Samoggia; E Montesoro; G Giannella; D Lazzaro; G Isacchi; U Testa
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

6.  Immune function of patients receiving recombinant human interleukin-6 (IL-6) in a phase I clinical study: induction of C-reactive protein and IgE and inhibition of natural killer and lymphokine-activated killer cell activity.

Authors:  C Scheid; R Young; R McDermott; L Fitzsimmons; J H Scarffe; P L Stern
Journal:  Cancer Immunol Immunother       Date:  1994-02       Impact factor: 6.968

7.  Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.

Authors:  H C Reinecker; M Steffen; T Witthoeft; I Pflueger; S Schreiber; R P MacDermott; A Raedler
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

8.  Expression of interleukin-6 receptor on blood lymphocytes without in vitro activation.

Authors:  H Zola; L Flego
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

9.  Neurotrophins regulate bone marrow stromal cell IL-6 expression through the MAPK pathway.

Authors:  Fariba Rezaee; Stephanie L Rellick; Giovanni Piedimonte; Stephen M Akers; Heather A O'Leary; Karen Martin; Michael D Craig; Laura F Gibson
Journal:  PLoS One       Date:  2010-03-15       Impact factor: 3.240

10.  Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.

Authors:  B Ryffel; B D Car; H Gunn; D Roman; P Hiestand; M J Mihatsch
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.